Intensity-Modulated Radiation Therapy Provides Long-Term Benefits to Patients With Locally Advanced Lung Cancer

Development and Validation of a Novel TNM Staging N-Classification of Oral Cavity Squamous Cell Carcinoma

Utilizing Biomarkers to Optimize Treatment for Upper Gastrointestinal Cancers

Survival Benefit With Checkpoint Inhibitors Versus Chemotherapy is Modified by Brain Metastases in Patients With Recurrent Small-Cell Lung Cancer

Evaluating Strategies and Approaches to Prevent Graft-Versus-Host Disease

ChatGPT's Limited Ability to Recommend Guideline-Based Cancer Treatments

Response Assessment of Post-Treatment Head and Neck Cancers to Determine Further Management Using NI-RADS (Neck Imaging Reporting and Data System): A Subgroup Analysis of a Randomized Controlled Trial

IDEAYA Biosciences Receives Fast Track Designation for IDE161 in a Second Indication for the Treatment of Pretreated, Advanced or Metastatic HR+, HER2-, BRCA1/2 Mutant Breast Cancer

Intensity-Modulated Radiation Therapy Provides Long-Term Benefits to Patients With Locally Advanced Lung Cancer

header-info

Sep, 12, 2023

Based on results from the phase 3 NRG Oncology-RTOG 0617 study, researchers have identified that patients who receive IMRT experience greater reduction in severe lung inflammation compared to patients who receive 3D-conformal radiotherapy. These findings were presented at the 2023 World Conference on Lung Cancer.

Access the full article to read more here.